Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
BNGO Bionano Genomics
- 0.2370
- -0.0173-6.80%
Close Dec 3 16:00 ET
- 0.2450
- +0.0080+3.38%
Post 20:01 ET
24.17MMarket Cap-103P/E (TTM)
0.2600High0.2296Low3.30MVolume0.2567Open0.2543Pre Close784.75KTurnover3.24%Turnover RatioLossP/E (Static)101.99MShares2.270052wk High0.49P/B24.12MFloat Cap0.200052wk Low--Dividend TTM101.77MShs Float156.9000Historical High--Div YieldTTM11.95%Amplitude0.2000Historical Low0.2380Avg Price1Lot Size
About Bionano Genomics Company
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Company Profile
SymbolBNGO
Company NameBionano Genomics
Listing DateSep 21, 2018
Issue Price6.13
Founded2007
CEODr. R. Erik Holmlin, PhD
MarketNASDAQ
Employees344
Fiscal Year Ends12-31
Address9540 Towne Centre Drive,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-888-7600
Websitehttp://www.bionano.com
Company Executives
- Name
- Position
- Salary
- Dr. R. Erik Holmlin, PhD
- President, Chief Executive Officer, Principal Financial Officer and Director
- 1.25M
- Mark Oldakowski
- Chief Operating Officer
- 884.78K
- Alka Chaubey
- Chief Medical Officer
- 864.78K
- Mark Adamchak
- Principal Accounting Officer
- --
- Dr. David L. Barker, PhD
- Chairman of the Board
- 97.75K
- Hannah Mamuszka
- Independent Director
- 60.25K
- Dr. Yvonne Linney, PhD
- Independent Director
- 57.75K
- Dr. Albert A. Luderer, PhD
- Independent Director
- 77.75K
- Vincent Jung-Fai Wong, J.D.,M.B.A.
- Independent Director
- 62.75K
- Dr. Kristiina Vuori, M.D.,PhD
- Independent Director
- 70.25K
- Christopher J. Twomey
- Independent Director
- 72.75K
- Dr. Aleksandar Rajkovic, M.D.,PhD
- Independent Director
- 57.75K
- Jonathan V. Dixon
- General Counsel and Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.